首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.
【24h】

Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

机译:哮喘控制测试:以前没有哮喘专家随访的患者的信度,效度和反应性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The development of the Asthma Control Test (ACT), a short, simple, patient-based tool for identifying patients with poorly controlled asthma, was recently described in patients under the routine care of an asthma specialist. OBJECTIVES: We sought to evaluate the reliability and validity of the ACT in a longitudinal study of asthmatic patients new to the care of an asthma specialist. METHODS: Patients (n=313) completed the ACT and the Asthma Control Questionnaire (ACQ) at 2 physician visits (4-12 weeks apart). Pulmonary function was measured, and asthma specialists rated asthma control. RESULTS: Internal consistency reliability of the ACT was 0.85 (baseline) and 0.79 (follow-up). Test-retest reliability was 0.77. Criterion validity was demonstrated by significant correlations between baseline ACT scores and baseline specialists' ratings of asthma control (r=0.52, P<.001) and ACQ scores (r=-0.89, P<.001). Discriminant validity was demonstrated, with significant (P<.001) differences in mean ACT scores across patients differing in asthma control, pulmonary function, and treatment recommendation. Responsiveness of the ACT to changes in asthma control and lung function was demonstrated with significant correlations between changes in ACT scores and changes in specialists' ratings (r=0.44, P<.001), ACQ scores (r=-0.69, P<.001), and percent predicted FEV1 values (r=0.29, P<.001). An ACT score of 19 or less provided optimum balance of sensitivity (71%) and specificity (71%) for detecting uncontrolled asthma. CONCLUSIONS: The ACT is reliable, valid, and responsive to changes in asthma control over time in patients new to the care of asthma specialists. A cutoff score of 19 or less identifies patients with poorly controlled asthma. CLINICAL IMPLICATIONS: In a clinical setting the ACT should be a useful tool to help physicians identify patients with uncontrolled asthma and facilitate their ability to follow patients' progress with treatment.
机译:背景:哮喘控制测试(ACT)的开发是一种简短,简单,以患者为基础的工具,用于识别哮喘控制不佳的患者,最近在哮喘专家的常规护理下进行了描述。目的:我们试图在一项哮喘专家的纵向研究中评估ACT的可靠性和有效性。方法:患者(n = 313)在2次就诊时(相隔4-12周)完成了ACT和哮喘控制问卷(ACQ)。测量肺功能,哮喘专家对哮喘控制进行评估。结果:ACT的内部一致性可靠性为0.85(基线)和0.79(随访)。重测信度为0.77。基线ACT评分与基线专家对哮喘控制的评分(r = 0.52,P <.001)和ACQ评分(r = -0.89,P <.001)之间的显着相关性证明了标准的有效性。证明了判别有效性,在哮喘控制,肺功能和治疗建议不同的患者中,平均ACT评分存在显着(P <.001)差异。 ACT对哮喘控制和肺功能变化的反应性与ACT评分的变化与专家评分的变化(r = 0.44,P <.001),ACQ评分(r = -0.69,P <)之间具有显着相关性。 001),以及预测的FEV1百分比值(r = 0.29,P <.001)。 ACT分数等于或小于19可以为检测不受控制的哮喘提供灵敏度(71%)和特异性(71%)的最佳平衡。结论:ACT是可靠,有效的,并且对哮喘专科医师治疗的新患者的哮喘控制随时间变化有响应。截断分数等于或小于19表示哮喘控制不佳的患者。临床意义:在临床环境中,ACT应该是有用的工具,可帮助医生识别哮喘不受控制的患者,并提高他们追踪患者治疗进展的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号